ECM
OXFD
Endurant Capital Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-2,240,421
| Closed | -$39.1M | – | 79 |
|
2020
Q4 | $39.1M | Buy |
2,240,421
+485,956
| +28% | +$8.49M | 14.11% | 1 |
|
2020
Q3 | $20.5M | Buy |
1,754,465
+357,670
| +26% | +$4.18M | 6.07% | 2 |
|
2020
Q2 | $18.2M | Sell |
1,396,795
-299,093
| -18% | -$3.89M | 1% | 1 |
|
2020
Q1 | $15.7M | Buy |
1,695,888
+477,859
| +39% | +$4.42M | 7.12% | 5 |
|
2019
Q4 | $20.2M | Buy |
1,218,029
+228,593
| +23% | +$3.79M | 6.37% | 4 |
|
2019
Q3 | $16.5M | Buy |
989,436
+360,200
| +57% | +$5.99M | 5.91% | 4 |
|
2019
Q2 | $8.66M | Buy |
629,236
+526,643
| +513% | +$7.25M | 3.41% | 9 |
|
2019
Q1 | $1.77M | Sell |
102,593
-358,641
| -78% | -$6.18M | 0.7% | 40 |
|
2018
Q4 | $5.9M | Buy |
461,234
+166,005
| +56% | +$2.12M | 3.12% | 12 |
|
2018
Q3 | $4.79M | Buy |
295,229
+138,360
| +88% | +$2.25M | 2.13% | 16 |
|
2018
Q2 | $2.02M | Sell |
156,869
-8,300
| -5% | -$107K | 0.88% | 30 |
|
2018
Q1 | $2.06M | Sell |
165,169
-405,256
| -71% | -$5.04M | 0.77% | 36 |
|
2017
Q4 | $7.97M | Sell |
570,425
-161,084
| -22% | -$2.25M | 2.44% | 16 |
|
2017
Q3 | $12.3M | Sell |
731,509
-19,025
| -3% | -$320K | 3.72% | 3 |
|
2017
Q2 | $12.6M | Buy |
750,534
+179,563
| +31% | +$3.02M | 3.57% | 3 |
|
2017
Q1 | $8.84M | Buy |
570,971
+554,915
| +3,456% | +$8.6M | 2.84% | 10 |
|
2016
Q4 | $240K | Sell |
16,056
-95,599
| -86% | -$1.43M | 0.1% | 66 |
|
2016
Q3 | $1.4M | Buy |
+111,655
| New | +$1.4M | 0.52% | 43 |
|